Hypogonadism is the only FDA-approved use for testosterone therapy in the United States, yet millions of men use hormone-laden gels, patches and creams to combat normal signs of aging, thanks to aggressive and misleading marketing by various drug manufacturers. Hypogonadism is marked by clinically low... Read More

An Alabama couple has filed an AndroGel lawsuit against AbbVie Inc. and Abbot Laboratories Inc., the makers of the product. On November 20, 2012, Richard Freeman was prescribed AndroGel to treat symptoms caused by low levels of testosterone. Shortly after, in February 2013, he began... Read More

An increasing number of men have been filing product liability lawsuits against the manufacturers of testosterone therapy drugs, alleging that testosterone therapy increases the risk of heart attacks and other life-threatening complications. Several clinical studies have substantiated these claims, including a recent study published in... Read More

Amid international concerns that testosterone therapies like Androgel, AndroDerm, Axiron, and Testim are over-prescribed with unknown consequences, the European Medicines Agency has issued an updated statement on their use. “The product information should make it clear that testosterone should only be used when an abnormally low... Read More

Coordinated litigation involving Androgel lawsuits continues to progress in an Illinois court, with a tentative schedule for early trials to begin in late 2016. The case management plan, created by U.S. District Judge Matthew Kennelly in the Northern District of Illinois, outlines a process by... Read More

Multidistrict litigation (MDL) is an often-used procedural option that allows litigants from multiple jurisdictions the opportunity to consolidate their cases into one federal court. Unlike a class action, cases consolidated under MDL rules remain distinct and separate matters – however routine hearings and matters common... Read More

The safety of testosterone therapy has come under increasing scrutiny as a growing body of studies has associated these products with an increased risk of life-threatening cardiovascular events. Now, the FDA is getting involved. On September 17, 2014, an expert panel for the FDA voiced its concern... Read More

After the serious risks of testosterone replacement products came to light about nine months ago, testosterone drug lawsuits have been piling up against the manufacturers. About 200 of those cases have been centralized into a multidistrict litigation (MDL), which is proceeding in the U.S. District... Read More